S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

BRTX BioRestorative Therapies Inc

2.48

0.076 (3.16%)

01 Feb 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

BioRestorative Therapies (NASDAQ:BRTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more BioRestorative Therapies Charts.

BioRestorative Therapies (NASDAQ:BRTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more BioRestorative Therapies Charts.

BioRestorative Therapies Inc News

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 6 December 2024 (2 months ago) • Edgar (US Regulatory)

BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program
Thursday 5 December 2024 (2 months ago) • GlobeNewswire Inc.

BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
Wednesday 13 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
Wednesday 13 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
Wednesday 6 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 November 2024 (3 months ago) • Edgar (US Regulatory)

BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
Tuesday 5 November 2024 (3 months ago) • GlobeNewswire Inc.

BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program
Thursday 31 October 2024 (3 months ago) • GlobeNewswire Inc.

More BioRestorative Therapies Inc News Articles

Woodside Petroleum

Newcrest Mining

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions